|
Restatement Of Condensed Consolidated Financial Statements (Condensed Consolidated Statements Of Cash Flow) (Detail) (USD $) In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2010
|
| Cash flows from operating activities of continuing operations |
|
|
|
| Net income / (loss) |
$ 363,238 |
$ 1,325,620 |
$ 150,929 |
| Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities: |
|
|
|
| Net (income) / loss from discontinued operations |
0 |
0 |
8,405 |
| Depreciation and amortization |
20,377 |
19,718 |
16,947 |
| Deferred income taxes |
(3,605) |
39,042 |
(27,944) |
| Unrealized foreign exchange (gains) / losses |
(93,772) |
138,845 |
(2,911) |
| Cost of debt extinguishment |
0 |
0 |
14,114 |
| Stock options fair value expense |
2,953 |
2,605 |
3,206 |
| Dividends received |
0 |
0 |
10,859 |
| Equity (income)/loss in affiliates |
0 |
7,946 |
(13,386) |
| Gain on fair value remeasurement of previously held equity interest |
0 |
(7,898) |
0 |
| Impairment charge |
372,899 |
1,057,819 |
131,849 |
| Impairments related to assets held for sale |
675 |
7,355 |
0 |
| Other non cash items |
8,191 |
4,345 |
25,343 |
| Changes in operating assets and liabilities: |
|
|
|
| Accounts receivable |
82,651 |
74,606 |
25,399 |
| Inventories |
(46,155) |
(7,413) |
(4,024) |
| Prepayments and other current assets |
(51,821) |
(2,357) |
1,966 |
| Trade accounts payable |
(32,526) |
16,519 |
(16,874) |
| Other accrued liabilities and payables |
4,419 |
4,474 |
(50,137) |
| Net cash provided by / (used in) operating activities from continuing operations |
(98,952) |
29,986 |
(28,117) |
| Cash flows from investing activities of continuing operations |
|
|
|
| Purchase of fixed assets |
(9,374) |
(15,094) |
(6,194) |
| Proceeds from the disposal of fixed assets |
659 |
511 |
0 |
| Purchase of intangibles (licenses) |
0 |
(693) |
0 |
| Purchase of trademarks |
0 |
(17,473) |
(6,000) |
| Changes in restricted cash |
0 |
0 |
481,419 |
| Disposal of subsidiaries |
0 |
0 |
124,160 |
| Acquisitions of subsidiaries, net of cash acquired |
0 |
(24,124) |
(128,464) |
| Net cash provided by / (used in) investing activities from continuing operations |
(8,715) |
(56,873) |
464,921 |
| Cash flows from financing activities of continuing operations |
|
|
|
| Borrowings on bank loans and overdraft facility |
122,803 |
57,512 |
63,853 |
| Payment of bank loans, overdraft facility and other borrowings |
(77,652) |
(47,417) |
(174,251) |
| Payment of long-term borrowings |
0 |
0 |
(19,098) |
| Net borrowings of Senior Secured Notes |
0 |
0 |
67,561 |
| Payment of Senior Secured Notes |
0 |
0 |
(367,954) |
| Decrease in short term capital leases payable |
(566) |
(76) |
(501) |
| Options exercised |
0 |
72 |
3,550 |
| Net cash (used in) / provided by financing activities from continuing operations |
93,225 |
10,091 |
(426,840) |
| Cash flows from discontinued operations |
|
|
|
| Net cash provided by / (used in) operating activities of discontinued operations |
0 |
0 |
2,806 |
| Net cash (used in) investing activities of discontinued operations |
0 |
0 |
(330) |
| Net cash provided by / (used in) financing activities of discontinued operations |
0 |
0 |
100 |
| Net cash provided by/(used in) discontinued operations |
0 |
0 |
2,576 |
| Adjustment to reconcile the change in cash balances of discontinued operations |
0 |
0 |
(2,576) |
| Currency effect on brought forward cash balances |
4,761 |
(10,910) |
(14,287) |
| Net increase / (decrease) in cash |
(9,681) |
(27,706) |
(4,323) |
| Cash and cash equivalents at beginning of period |
94,410 |
122,116 |
126,439 |
| Cash and cash equivalents at end of period |
84,729 |
94,410 |
122,116 |
| Supplemental Schedule of Non-cash Investing Activities |
|
|
|
| Common stock issued in connection with investment in subsidiaries |
0 |
23,174 |
41,344 |
| Supplemental disclosures of cash flow information |
|
|
|
| Interest paid |
101,633 |
103,836 |
111,535 |
| Income tax paid |
5,750 |
5,139 |
29,544 |
|
As previously reported
|
|
|
|
| Cash flows from operating activities of continuing operations |
|
|
|
| Net income / (loss) |
|
(1,323,384) |
(138,073) |
| Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities: |
|
|
|
| Net (income) / loss from discontinued operations |
|
|
8,405 |
| Depreciation and amortization |
|
19,718 |
16,947 |
| Deferred income taxes |
|
36,806 |
(40,800) |
| Unrealized foreign exchange (gains) / losses |
|
138,845 |
(2,911) |
| Cost of debt extinguishment |
|
|
14,114 |
| Stock options fair value expense |
|
2,605 |
3,206 |
| Dividends received |
|
|
10,859 |
| Equity (income)/loss in affiliates |
|
7,946 |
(13,386) |
| Gain on fair value remeasurement of previously held equity interest |
|
(7,898) |
|
| Impairment charge |
|
1,057,819 |
131,849 |
| Impairments related to assets held for sale |
|
7,355 |
|
| Other non cash items |
|
4,345 |
25,343 |
| Changes in operating assets and liabilities: |
|
|
|
| Accounts receivable |
|
74,606 |
25,399 |
| Inventories |
|
(7,413) |
(4,024) |
| Prepayments and other current assets |
|
(2,357) |
1,966 |
| Trade accounts payable |
|
16,519 |
(16,874) |
| Other accrued liabilities and payables |
|
4,474 |
(50,137) |
| Net cash provided by / (used in) operating activities from continuing operations |
|
29,986 |
(28,117) |
| Cash flows from investing activities of continuing operations |
|
|
|
| Purchase of fixed assets |
|
(15,094) |
(6,194) |
| Proceeds from the disposal of fixed assets |
|
511 |
|
| Purchase of intangibles (licenses) |
|
(693) |
|
| Purchase of trademarks |
|
(17,473) |
(6,000) |
| Changes in restricted cash |
|
|
481,419 |
| Disposal of subsidiaries |
|
|
124,160 |
| Acquisitions of subsidiaries, net of cash acquired |
|
(24,124) |
(128,464) |
| Net cash provided by / (used in) investing activities from continuing operations |
|
(56,873) |
464,921 |
| Cash flows from financing activities of continuing operations |
|
|
|
| Borrowings on bank loans and overdraft facility |
|
57,512 |
63,853 |
| Payment of bank loans, overdraft facility and other borrowings |
|
(47,417) |
(174,251) |
| Payment of long-term borrowings |
|
|
(19,098) |
| Net borrowings of Senior Secured Notes |
|
|
67,561 |
| Payment of Senior Secured Notes |
|
|
(367,954) |
| Decrease in short term capital leases payable |
|
(76) |
(501) |
| Increase in short term capital leases payable |
|
|
0 |
| Transactions with equity holders |
|
|
0 |
| Options exercised |
|
72 |
3,550 |
| Net cash (used in) / provided by financing activities from continuing operations |
|
10,091 |
(426,840) |
| Cash flows from discontinued operations |
|
|
|
| Net cash provided by / (used in) operating activities of discontinued operations |
|
|
2,806 |
| Net cash (used in) investing activities of discontinued operations |
|
|
(330) |
| Net cash provided by / (used in) financing activities of discontinued operations |
|
|
100 |
| Net cash provided by/(used in) discontinued operations |
|
|
2,576 |
| Adjustment to reconcile the change in cash balances of discontinued operations |
|
|
(2,576) |
| Currency effect on brought forward cash balances |
|
(10,910) |
(14,287) |
| Net increase / (decrease) in cash |
|
(27,706) |
(4,323) |
| Cash and cash equivalents at beginning of period |
|
122,116 |
126,439 |
| Cash and cash equivalents at end of period |
|
94,410 |
122,116 |
| Supplemental Schedule of Non-cash Investing Activities |
|
|
|
| Common stock issued in connection with investment in subsidiaries |
|
23,174 |
41,344 |
| Supplemental disclosures of cash flow information |
|
|
|
| Interest paid |
|
103,836 |
111,535 |
| Income tax paid |
|
5,139 |
29,544 |
|
Adjustment
|
|
|
|
| Cash flows from operating activities of continuing operations |
|
|
|
| Net income / (loss) |
|
(2,236) |
(12,856) |
| Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities: |
|
|
|
| Net (income) / loss from discontinued operations |
|
|
0 |
| Depreciation and amortization |
|
0 |
0 |
| Deferred income taxes |
|
2,236 |
12,856 |
| Unrealized foreign exchange (gains) / losses |
|
0 |
0 |
| Cost of debt extinguishment |
|
|
0 |
| Stock options fair value expense |
|
0 |
0 |
| Dividends received |
|
|
0 |
| Equity (income)/loss in affiliates |
|
0 |
0 |
| Gain on fair value remeasurement of previously held equity interest |
|
0 |
|
| Impairment charge |
|
0 |
0 |
| Impairments related to assets held for sale |
|
0 |
|
| Other non cash items |
|
0 |
0 |
| Changes in operating assets and liabilities: |
|
|
|
| Accounts receivable |
|
0 |
0 |
| Inventories |
|
0 |
0 |
| Prepayments and other current assets |
|
0 |
0 |
| Trade accounts payable |
|
0 |
0 |
| Other accrued liabilities and payables |
|
0 |
0 |
| Net cash provided by / (used in) operating activities from continuing operations |
|
0 |
0 |
| Cash flows from investing activities of continuing operations |
|
|
|
| Purchase of fixed assets |
|
0 |
0 |
| Proceeds from the disposal of fixed assets |
|
0 |
|
| Purchase of intangibles (licenses) |
|
0 |
|
| Purchase of trademarks |
|
0 |
0 |
| Changes in restricted cash |
|
|
0 |
| Disposal of subsidiaries |
|
|
0 |
| Acquisitions of subsidiaries, net of cash acquired |
|
0 |
0 |
| Net cash provided by / (used in) investing activities from continuing operations |
|
0 |
0 |
| Cash flows from financing activities of continuing operations |
|
|
|
| Borrowings on bank loans and overdraft facility |
|
0 |
0 |
| Payment of bank loans, overdraft facility and other borrowings |
|
0 |
0 |
| Payment of long-term borrowings |
|
|
0 |
| Net borrowings of Senior Secured Notes |
|
|
0 |
| Payment of Senior Secured Notes |
|
|
0 |
| Decrease in short term capital leases payable |
|
0 |
0 |
| Increase in short term capital leases payable |
|
|
0 |
| Transactions with equity holders |
|
|
0 |
| Options exercised |
|
0 |
0 |
| Net cash (used in) / provided by financing activities from continuing operations |
|
0 |
0 |
| Cash flows from discontinued operations |
|
|
|
| Net cash provided by / (used in) operating activities of discontinued operations |
|
|
0 |
| Net cash (used in) investing activities of discontinued operations |
|
|
0 |
| Net cash provided by / (used in) financing activities of discontinued operations |
|
|
0 |
| Net cash provided by/(used in) discontinued operations |
|
|
0 |
| Adjustment to reconcile the change in cash balances of discontinued operations |
|
|
0 |
| Currency effect on brought forward cash balances |
|
0 |
0 |
| Net increase / (decrease) in cash |
|
0 |
0 |
| Cash and cash equivalents at beginning of period |
|
0 |
0 |
| Cash and cash equivalents at end of period |
|
0 |
0 |
| Supplemental Schedule of Non-cash Investing Activities |
|
|
|
| Common stock issued in connection with investment in subsidiaries |
|
0 |
0 |
| Supplemental disclosures of cash flow information |
|
|
|
| Interest paid |
|
0 |
0 |
| Income tax paid |
|
0 |
0 |
|
Restated
|
|
|
|
| Cash flows from operating activities of continuing operations |
|
|
|
| Net income / (loss) |
|
(1,325,620) |
(150,929) |
| Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities: |
|
|
|
| Net (income) / loss from discontinued operations |
|
|
8,405 |
| Depreciation and amortization |
|
19,718 |
16,947 |
| Deferred income taxes |
|
39,042 |
(27,944) |
| Unrealized foreign exchange (gains) / losses |
|
138,845 |
(2,911) |
| Cost of debt extinguishment |
|
|
14,114 |
| Stock options fair value expense |
|
2,605 |
3,206 |
| Dividends received |
|
|
10,859 |
| Equity (income)/loss in affiliates |
|
7,946 |
(13,386) |
| Gain on fair value remeasurement of previously held equity interest |
|
(7,898) |
|
| Impairment charge |
|
1,057,819 |
131,849 |
| Impairments related to assets held for sale |
|
7,355 |
|
| Other non cash items |
|
4,345 |
25,343 |
| Changes in operating assets and liabilities: |
|
|
|
| Accounts receivable |
|
74,606 |
25,399 |
| Inventories |
|
(7,413) |
(4,024) |
| Prepayments and other current assets |
|
(2,357) |
1,966 |
| Trade accounts payable |
|
16,519 |
(16,874) |
| Other accrued liabilities and payables |
|
4,474 |
(50,137) |
| Net cash provided by / (used in) operating activities from continuing operations |
|
29,986 |
(28,117) |
| Cash flows from investing activities of continuing operations |
|
|
|
| Purchase of fixed assets |
|
(15,094) |
(6,194) |
| Proceeds from the disposal of fixed assets |
|
511 |
|
| Purchase of intangibles (licenses) |
|
(693) |
|
| Purchase of trademarks |
|
(17,473) |
(6,000) |
| Changes in restricted cash |
|
|
481,419 |
| Disposal of subsidiaries |
|
|
124,160 |
| Acquisitions of subsidiaries, net of cash acquired |
|
(24,124) |
(128,464) |
| Net cash provided by / (used in) investing activities from continuing operations |
|
(56,873) |
464,921 |
| Cash flows from financing activities of continuing operations |
|
|
|
| Borrowings on bank loans and overdraft facility |
|
57,512 |
63,853 |
| Payment of bank loans, overdraft facility and other borrowings |
|
(47,417) |
(174,251) |
| Payment of long-term borrowings |
|
|
(19,098) |
| Net borrowings of Senior Secured Notes |
|
|
67,561 |
| Payment of Senior Secured Notes |
|
|
(367,954) |
| Decrease in short term capital leases payable |
|
(76) |
(501) |
| Increase in short term capital leases payable |
|
|
0 |
| Transactions with equity holders |
|
|
0 |
| Options exercised |
|
72 |
3,550 |
| Net cash (used in) / provided by financing activities from continuing operations |
|
10,091 |
(426,840) |
| Cash flows from discontinued operations |
|
|
|
| Net cash provided by / (used in) operating activities of discontinued operations |
|
|
2,806 |
| Net cash (used in) investing activities of discontinued operations |
|
|
(330) |
| Net cash provided by / (used in) financing activities of discontinued operations |
|
|
100 |
| Net cash provided by/(used in) discontinued operations |
|
|
2,576 |
| Adjustment to reconcile the change in cash balances of discontinued operations |
|
|
(2,576) |
| Currency effect on brought forward cash balances |
|
(10,910) |
(14,287) |
| Net increase / (decrease) in cash |
|
(27,706) |
(4,323) |
| Cash and cash equivalents at beginning of period |
|
122,116 |
126,439 |
| Cash and cash equivalents at end of period |
|
94,410 |
122,116 |
| Supplemental Schedule of Non-cash Investing Activities |
|
|
|
| Common stock issued in connection with investment in subsidiaries |
|
23,174 |
41,344 |
| Supplemental disclosures of cash flow information |
|
|
|
| Interest paid |
|
103,836 |
111,535 |
| Income tax paid |
|
$ 5,139 |
$ 29,544 |